<!DOCTYPE html>
<!--
==============================================================================
           "GitHub HTML5 Pandoc Template" v2.1 — by Tristano Ajmone           
==============================================================================
Copyright © Tristano Ajmone, 2017, MIT License (MIT). Project's home:

- https://github.com/tajmone/pandoc-goodies

The CSS in this template reuses source code taken from the following projects:

- GitHub Markdown CSS: Copyright © Sindre Sorhus, MIT License (MIT):
  https://github.com/sindresorhus/github-markdown-css

- Primer CSS: Copyright © 2016-2017 GitHub Inc., MIT License (MIT):
  http://primercss.io/

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The MIT License 

Copyright (c) Tristano Ajmone, 2017 (github.com/tajmone/pandoc-goodies)
Copyright (c) Sindre Sorhus <sindresorhus@gmail.com> (sindresorhus.com)
Copyright (c) 2017 GitHub Inc.

"GitHub Pandoc HTML5 Template" is Copyright (c) Tristano Ajmone, 2017, released
under the MIT License (MIT); it contains readaptations of substantial portions
of the following third party softwares:

(1) "GitHub Markdown CSS", Copyright (c) Sindre Sorhus, MIT License (MIT).
(2) "Primer CSS", Copyright (c) 2016 GitHub Inc., MIT License (MIT).

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
==============================================================================-->
<html>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Acute rheumatic fever  MeG-CLS-048</title>
  <style type="text/css">
@charset "UTF-8";.markdown-body{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;color:#24292e;font-family:-apple-system,system-ui,BlinkMacSystemFont,"Segoe UI",Helvetica,Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol";font-size:16px;line-height:1.5;word-wrap:break-word;box-sizing:border-box;min-width:200px;max-width:980px;margin:0 auto;padding:45px}.markdown-body a{color:#0366d6;background-color:transparent;text-decoration:none;-webkit-text-decoration-skip:objects}.markdown-body a:active,.markdown-body a:hover{outline-width:0}.markdown-body a:hover{text-decoration:underline}.markdown-body a:not([href]){color:inherit;text-decoration:none}.markdown-body strong{font-weight:600}.markdown-body h1,.markdown-body h2,.markdown-body h3,.markdown-body h4,.markdown-body h5,.markdown-body h6{margin-top:24px;margin-bottom:16px;font-weight:600;line-height:1.25}.markdown-body h1{font-size:2em;margin:.67em 0;padding-bottom:.3em;border-bottom:1px solid #eaecef}.markdown-body h2{padding-bottom:.3em;font-size:1.5em;border-bottom:1px solid #eaecef}.markdown-body h3{font-size:1.25em}.markdown-body h4{font-size:1em}.markdown-body h5{font-size:.875em}.markdown-body h6{font-size:.85em;color:#6a737d}.markdown-body img{border-style:none}.markdown-body svg:not(:root){overflow:hidden}.markdown-body hr{box-sizing:content-box;height:.25em;margin:24px 0;padding:0;overflow:hidden;background-color:#e1e4e8;border:0}.markdown-body hr::before{display:table;content:""}.markdown-body hr::after{display:table;clear:both;content:""}.markdown-body input{margin:0;overflow:visible;font:inherit;font-family:inherit;font-size:inherit;line-height:inherit}.markdown-body [type=checkbox]{box-sizing:border-box;padding:0}.markdown-body *{box-sizing:border-box}.markdown-body blockquote{margin:0}.markdown-body ol,.markdown-body ul{padding-left:2em}.markdown-body ol ol,.markdown-body ul ol{list-style-type:lower-roman}.markdown-body ol ol,.markdown-body ol ul,.markdown-body ul ol,.markdown-body ul ul{margin-top:0;margin-bottom:0}.markdown-body ol ol ol,.markdown-body ol ul ol,.markdown-body ul ol ol,.markdown-body ul ul ol{list-style-type:lower-alpha}.markdown-body li>p{margin-top:16px}.markdown-body li+li{margin-top:.25em}.markdown-body dd{margin-left:0}.markdown-body dl{padding:0}.markdown-body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:600}.markdown-body dl dd{padding:0 16px;margin-bottom:16px}.markdown-body code{font-family:SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace}.markdown-body pre{font:12px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;word-wrap:normal}.markdown-body blockquote,.markdown-body dl,.markdown-body ol,.markdown-body p,.markdown-body pre,.markdown-body table,.markdown-body ul{margin-top:0;margin-bottom:16px}.markdown-body blockquote{padding:0 1em;color:#6a737d;border-left:.25em solid #dfe2e5}.markdown-body blockquote>:first-child{margin-top:0}.markdown-body blockquote>:last-child{margin-bottom:0}.markdown-body table{display:block;width:100%;overflow:auto;border-spacing:0;border-collapse:collapse}.markdown-body table th{font-weight:600}.markdown-body table td,.markdown-body table th{padding:6px 13px;border:1px solid #dfe2e5}.markdown-body table tr{background-color:#fff;border-top:1px solid #c6cbd1}.markdown-body table tr:nth-child(2n){background-color:#f6f8fa}.markdown-body img{max-width:100%;box-sizing:content-box;background-color:#fff}.markdown-body code{padding:.2em 0;margin:0;font-size:85%;background-color:rgba(27,31,35,.05);border-radius:3px}.markdown-body code::after,.markdown-body code::before{letter-spacing:-.2em;content:" "}.markdown-body pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}.markdown-body .highlight{margin-bottom:16px}.markdown-body .highlight pre{margin-bottom:0;word-break:normal}.markdown-body .highlight pre,.markdown-body pre{padding:16px;overflow:auto;font-size:85%;line-height:1.45;background-color:#f6f8fa;border-radius:3px}.markdown-body pre code{display:inline;max-width:auto;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}.markdown-body pre code::after,.markdown-body pre code::before{content:normal}.markdown-body .full-commit .btn-outline:not(:disabled):hover{color:#005cc5;border-color:#005cc5}.markdown-body kbd{box-shadow:inset 0 -1px 0 #959da5;display:inline-block;padding:3px 5px;font:11px/10px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;color:#444d56;vertical-align:middle;background-color:#fcfcfc;border:1px solid #c6cbd1;border-bottom-color:#959da5;border-radius:3px;box-shadow:inset 0 -1px 0 #959da5}.markdown-body :checked+.radio-label{position:relative;z-index:1;border-color:#0366d6}.markdown-body .task-list-item{list-style-type:none}.markdown-body .task-list-item+.task-list-item{margin-top:3px}.markdown-body .task-list-item input{margin:0 .2em .25em -1.6em;vertical-align:middle}.markdown-body::before{display:table;content:""}.markdown-body::after{display:table;clear:both;content:""}.markdown-body>:first-child{margin-top:0!important}.markdown-body>:last-child{margin-bottom:0!important}.Alert,.Error,.Note,.Success,.Warning{padding:11px;margin-bottom:24px;border-style:solid;border-width:1px;border-radius:4px}.Alert p,.Error p,.Note p,.Success p,.Warning p{margin-top:0}.Alert p:last-child,.Error p:last-child,.Note p:last-child,.Success p:last-child,.Warning p:last-child{margin-bottom:0}.Alert{color:#246;background-color:#e2eef9;border-color:#bac6d3}.Warning{color:#4c4a42;background-color:#fff9ea;border-color:#dfd8c2}.Error{color:#911;background-color:#fcdede;border-color:#d2b2b2}.Success{color:#22662c;background-color:#e2f9e5;border-color:#bad3be}.Note{color:#2f363d;background-color:#f6f8fa;border-color:#d5d8da}.Alert h1,.Alert h2,.Alert h3,.Alert h4,.Alert h5,.Alert h6{color:#246;margin-bottom:0}.Warning h1,.Warning h2,.Warning h3,.Warning h4,.Warning h5,.Warning h6{color:#4c4a42;margin-bottom:0}.Error h1,.Error h2,.Error h3,.Error h4,.Error h5,.Error h6{color:#911;margin-bottom:0}.Success h1,.Success h2,.Success h3,.Success h4,.Success h5,.Success h6{color:#22662c;margin-bottom:0}.Note h1,.Note h2,.Note h3,.Note h4,.Note h5,.Note h6{color:#2f363d;margin-bottom:0}.Alert h1:first-child,.Alert h2:first-child,.Alert h3:first-child,.Alert h4:first-child,.Alert h5:first-child,.Alert h6:first-child,.Error h1:first-child,.Error h2:first-child,.Error h3:first-child,.Error h4:first-child,.Error h5:first-child,.Error h6:first-child,.Note h1:first-child,.Note h2:first-child,.Note h3:first-child,.Note h4:first-child,.Note h5:first-child,.Note h6:first-child,.Success h1:first-child,.Success h2:first-child,.Success h3:first-child,.Success h4:first-child,.Success h5:first-child,.Success h6:first-child,.Warning h1:first-child,.Warning h2:first-child,.Warning h3:first-child,.Warning h4:first-child,.Warning h5:first-child,.Warning h6:first-child{margin-top:0}h1.title,p.subtitle{text-align:center}h1.title.followed-by-subtitle{margin-bottom:0}p.subtitle{font-size:1.5em;font-weight:600;line-height:1.25;margin-top:0;margin-bottom:16px;padding-bottom:.3em}div.line-block{white-space:pre-line}
  </style>
  <style type="text/css">code{white-space: pre;}</style>
  <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv-printshiv.min.js"></script>
  <![endif]-->
</head>
<body>
<article class="markdown-body">
<h2 id="acute-rheumatic-fever">Acute Rheumatic Fever</h2>
<h2 id="executive-summary"><em>Executive summary</em></h2>
<h2 id="introduction">Introduction</h2>
<h1 id="acute-rheumatic-fever-arf-is-an-auto-immune-consequence-of-infection-with-the-bacterium-group-a-streptococcus-gas.-the-symptoms-usually-appear-2-4-weeks-following-infection.-it-causes-an-acute-generalised-inflammatory-response-and-an-illness-that-affects-only-certain-parts-of-the-body-mainly-the-heart-joints-brain-and-skin.">Acute rheumatic fever (ARF) is an auto-immune consequence of infection with the bacterium group A streptococcus (GAS). The symptoms usually appear 2-4 weeks following infection. It causes an acute generalised inflammatory response and an illness that affects only certain parts of the body, mainly the heart, joints, brain and skin. </h1>
<h1 id="arf-leaves-no-lasting-damage-to-the-brain-joints-or-skin.-however-the-damage-to-the-heart-or-more-specifically-the-mitral-andor-aortic-valves-may-remain-once-the-acute-episode-has-resolved-and-these-long-term-changes-are-termed-rheumatic-heart-disease-rhd.-because-of-its-high-prevalence-in-developing-countries-rhd-is-the-most-common-form-of-paediatric-heart-disease-globally.-in-many-countries-it-is-the-most-common-cause-of-cardiac-mortality-in-children-and-adults-aged-less-than-40-years.">ARF leaves no lasting damage to the brain, joints or skin. However, the damage to the heart, or more specifically the mitral and/or aortic valves, may remain once the acute episode has resolved and these long term changes are termed rheumatic heart disease (RHD). Because of its high prevalence in developing countries, RHD is the most common form of paediatric heart disease globally. In many countries, it is the most common cause of cardiac mortality in children and adults aged less than 40 years.</h1>
<h3 id="target-users">Target users</h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Doctors</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Nurses</p>
</div></li>
</ul>
<h3 id="target-area-of-use">Target area of use </h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Gate clinic</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>OPD</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ward</p>
</div></li>
</ul>
<h3 id="key-areas-of-focus-new-additions-changes">Key areas of focus / New additions / Changes </h3>
<h2 id="this-guideline-is-intended-to-support-clinicians-in-the-diagnosis-and-management-of-acute-rheumatic-fever-in-adults-and-children-who-present-to-csd.">This guideline is intended to support clinicians in the diagnosis and management of acute rheumatic fever in adults and children who present to CSD.</h2>
<h2 id="limitations">Limitations</h2>
<p>We do not currently have access to streptococcal antibody tests (Anti-DNAse B and Anti-Streptolysin Titre) which are highly useful investigations in acute rheumatic fever.</p>
<p>There is limited use of intramuscular Benzathine Penicillin G due to historical cases of severe adverse drug reaction. Throat culture is not routinely available at Keneba.</p>
<h2 id="presenting-symptoms-and-signs">Presenting symptoms and signs</h2>
<p>WHO criteria for the diagnosis of rheumatic fever are based on the revised Jones criteria:</p>
<table>
<thead>
<tr class="header">
<th><strong>Diagnostic category</strong></th>
<th><strong>Criteria</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Primary episode of ARF</td>
<td><p>2 major OR 1 major and 2 minor manifestations <strong>PLUS</strong></p>
<p>Evidence of a preceding GAS infection</p></td>
</tr>
<tr class="even">
<td>Recurrent attack of ARF in a patient <strong>without</strong> established rheumatic heart disease</td>
<td><p>2 major OR 1 major and 2 minor manifestations <strong>PLUS</strong></p>
<p>Evidence of a preceding GAS infection</p></td>
</tr>
<tr class="odd">
<td>Recurrent attack of ARF in a patient <strong>with</strong> established rheumatic heart disease</td>
<td><p>2 minor manifestations <strong>PLUS</strong></p>
<p>Evidence of a preceding GAS infection</p></td>
</tr>
</tbody>
</table>
<table>
<thead>
<tr class="header">
<th><strong>MAJOR MANIFESTATIONS</strong></th>
<th><strong>POINTS FOR DIAGNOSIS</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Arthritis</td>
<td><p>Most common presenting feature of ARF</p>
<p>Polyarthritis is usually asymmetrical and migratory</p>
<p>Monoarthritis may also be a presenting feature</p>
<p>Large joints are usually affected, especially the knees and ankles</p>
<p>Usually responds within 3 days of starting NSAID therapy</p></td>
</tr>
<tr class="even">
<td>Chorea</td>
<td><p>Consists of jerky, uncoordinated movements especially affecting the hands, feet, tongue and face</p>
<p>Disappears during sleep</p></td>
</tr>
<tr class="odd">
<td>Carditis</td>
<td>Usually presents as a pansystolic murmur over the apex or an early diastolic murmur at the left sternal edge</td>
</tr>
<tr class="even">
<td>Subcutaneous nodules</td>
<td>Present as crops of small, round, painless nodules over the elbows, wrists, knees, occiput and spinal processes</td>
</tr>
<tr class="odd">
<td>Erythema marginatum</td>
<td>Occurs as circular patterns of bright pink macules or papules on the trunk and proximal extremities</td>
</tr>
<tr class="even">
<td><strong>MINOR MANIFESTATIONS</strong></td>
<td><strong>POINTS FOR DIAGNOSIS</strong></td>
</tr>
<tr class="odd">
<td>Arthralgia</td>
<td>Migratory, asymmetrical and affecting large joints</td>
</tr>
<tr class="even">
<td>Fever</td>
<td><p>Most manifestations of ARF are accompanied by fever</p>
<p>A fever of ≥ 38 degrees meets this criteria</p></td>
</tr>
<tr class="odd">
<td>Elevated acute phase reactants</td>
<td>ESR (or CRP) ≥ 30 meets this criteria</td>
</tr>
</tbody>
</table>
<h2 id="differential-diagnosis">Differential diagnosis</h2>
<p>The following table outlines the features that can help differentiate between pharyngitis caused by GAS from that caused by a viral illness.</p>
<table>
<thead>
<tr class="header">
<th><strong>GAS infection</strong></th>
<th><strong>Viral infection</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><ul>
<li><div data-custom-style="List Paragraph">
<p>Sudden onset of sore throat</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Fever</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Headache</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Nausea, vomiting, abdominal pain</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Tonsillopharyngeal inflammation</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Tonsillopharyngeal exudates</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Palatal petechiae</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Enlarged anterior cervical lymph nodes</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Scarlatiniform rash</p>
</div></li>
</ul></td>
<td><ul>
<li><div data-custom-style="List Paragraph">
<p>Conjunctivitis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Coryza</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Cough</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Diarrhoea</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Hoarseness</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ulcerative stomatitis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Viral exanthema</p>
</div></li>
</ul></td>
</tr>
</tbody>
</table>
<h2 id="investigations">Investigations</h2>
<p>Patients should have the following:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Bloods: FBC, ESR, blood culture</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Throat swab</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>ECG</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Echocardiogram</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>CXR (if carditis suspected)</p>
</div></li>
</ul>
<p>Evidence of preceding GAS infection includes:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Elevated P-R interval on ECG: &gt; 0.16s (3-12 years), &gt; 0.18s (13-16 years), &gt;20s (≥ 17 years)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Elevated streptococcal antibodies</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Positive throat culture</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Recent scarlet fever</p>
</div></li>
</ul>
<h2 id="management">Management</h2>
<h3 id="primary-prevention-of-arf">Primary prevention of ARF </h3>
<ul>
<li><h1 id="all-patients-presenting-with-a-sore-throat-should-have-their-throat-examined.">All patients presenting with a sore throat should have their throat examined.</h1></li>
<li><h1 id="all-children-aged-4-15-years-who-present-with-a-fever-should-have-their-throat-examined-unless-clear-alternative-source-of-their-fever.">All children aged 4-15 years who present with a fever should have their throat examined (unless clear alternative source of their fever).</h1></li>
<li><h1 id="any-patient-who-has-features-suggestive-of-gas-and-all-children-aged-4-15-years-who-have-evidence-of-pharyngeal-inflammationexudate-should-be-treated-with-antibiotics-for-suspected-gas-infection.">Any patient who has features suggestive of GAS and all children aged 4-15 years who have evidence of pharyngeal inflammation/exudate should be treated with antibiotics for suspected GAS infection.</h1></li>
<li><h1 id="a-throat-swab-should-be-sent-for-culture-in-all-patients-who-are-being-treated-with-antibiotics-for-suspected-gas-infection.">A throat swab should be sent for culture in all patients who are being treated with antibiotics for suspected GAS infection.</h1></li>
</ul>
<h3 id="antibiotic-therapy-for-gas-infection">Antibiotic therapy for GAS infection</h3>
<table>
<thead>
<tr class="header">
<th><h1 id="for-patients-without-penicillin-allergy">For patients without penicillin allergy</h1></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><p>Penicillin V</p>
<p>(Phenoxymethylpenicillin)</p></td>
<td>Oral</td>
<td>7.5 mg/kg (max dose 500 mg) QDS</td>
<td>10 days</td>
</tr>
<tr class="even">
<td>Amoxicillin</td>
<td>Oral</td>
<td>50 mg/kg (max dose 1000 mg) OD</td>
<td>10 days</td>
</tr>
<tr class="odd">
<td>Benzathine penicillin G</td>
<td>Intramuscular</td>
<td><p>Weight &lt; 30 kg: 450 mg (600,000 units)</p>
<p>Weight ≥ 30 kg: 900 mg (1,200,000 units)</p></td>
<td>One dose</td>
</tr>
<tr class="even">
<td><strong>For patients with penicillin allergy</strong></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td>Erythromycin</td>
<td>Oral</td>
<td>20 mg/kg (max 500 mg) BD</td>
<td>10 days</td>
</tr>
</tbody>
</table>
<h3 id="treatment-of-arf">Treatment of ARF</h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p><strong>Antibiotics:</strong> All patients diagnosed with ARF should receive a course of antibiotics to treat GAS infection (see above on antibiotics).</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Analgesia/anti-inflammatories</strong>: Paracetamol may be sufficient for fever and mild arthralgia. Ibuprofen (10 mg/kg, maximum 500 mg, TDS) may be given for arthralgia or Aspirin (50-60 mg/kg/day, increased if needed to 80-100 mg/kg/day, given in 4-5 divided doses). Ibuprofen and aspirin may be used for more severe arthritis and pain but should only be started after a diagnosis of ARF has been made as they may mask the manifestations used to make the diagnosis.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Chorea:</strong> Can use carbamazepine (2-3 mg/kg TDS) for severe symptoms.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Carditis/heart failure:</strong> Diuretics and fluid restriction, use of ACE inhibitor and Digoxin if atrial fibrillation present.</p>
</div></li>
</ul>
<h3 id="secondary-prevention-of-arf">Secondary prevention of ARF</h3>
<p>Patients who develop recurrent episodes of ARF are at increased risk of worsening rheumatic heart disease. Therefore antibiotic prophylaxis is used in all patients who have had an episode of ARF to minimise the risk of recurrent episodes of GAS infection.</p>
<table>
<thead>
<tr class="header">
<th><div data-custom-style="Normal (Web)">
<p><strong>For patients without penicillin allergy</strong></p>
</div></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><p>Oral Penicillin V</p>
<p>(Phenoxymethylpenicillin)</p></td>
<td>7.5 mg/kg (max dose 500 mg) BD</td>
</tr>
<tr class="even">
<td><div data-custom-style="Normal (Web)">
<p><strong>For patients with penicillin allergy</strong></p>
</div></td>
<td></td>
</tr>
<tr class="odd">
<td>Oral Erythromycin</td>
<td>20 mg/kg (max dose 500 mg) BD</td>
</tr>
</tbody>
</table>
<h2 id="references">References</h2>
<p>New Zealand Guidelines for Rheumatic Fever- Diagnosis, Management and Secondary Prevention of Acute Rheumatic Fever and Rheumatic Heart Disease: 2014 Update</p>
<p>The Australian Guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (second edition)</p>
<p>AHA Guidelines on Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis</p>
<p>NICE guidelines: Sore throat (acute): antimicrobial prescribing, January 2018</p>
<table>
<thead>
<tr class="header">
<th><strong>Written by:</strong></th>
<th>Name: Lucy Affleck</th>
<th>Date: 20 November 2018</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Reviewed by:</strong></td>
<td>Name: Baderinwa Abatan</td>
<td>Date: 28 February 2019</td>
</tr>
<tr class="even">
<td><strong>Version:</strong></td>
<td><strong>Change history:</strong></td>
<td><strong>Review due date:</strong></td>
</tr>
<tr class="odd">
<td>1.0</td>
<td>New document</td>
<td>31 May 2021</td>
</tr>
<tr class="even">
<td>Review Comments (<em>if applicable)</em></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</article>
</body>
</html>
